Bendamustine, etoposide, cytarabine, melphalan, and autologous stem cell rescue produce a 72% 3-year PFS in resistant lymphoma.
Visani G, Stefani PM, Capria S, Malerba L, Galieni P, Gaudio F, Specchia G, Meloni G, Gherlinzoni F, Gonella R, Gobbi M, Santoro A, Ferrara F, Rocchi M, Ocio EM, Caballero MD, Loscocco F, Isidori A.
Visani G, et al. Among authors: isidori a.
Blood. 2014 Nov 6;124(19):3029-31. doi: 10.1182/blood-2014-08-596668.
Blood. 2014.
PMID: 25377565
Free article.
Clinical Trial.
No abstract available.